Evidence map›Paper›PMID 33263447›Full record

Trial reportActa orthopaedica2021

Reduced wear in vitamin E-infused highly cross-linked polyethylene cups: 5-year results of a randomized controlled trial.

Goulven Rochcongar, Matthieu Remazeilles, Emeline Bourroux, Julien Dunet, Valentin Chapus, Matthieu Feron, César Praz, Geoffrey Buia, Christophe Hulet

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Acta orthopaedica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Goulven RochcongarCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Matthieu RemazeillesCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Emeline BourrouxCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Julien DunetCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Valentin ChapusCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Matthieu FeronCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
César PrazCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Geoffrey BuiaCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Christophe HuletCaen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.
Université de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose - Vitamin E-infused polyethylene is a relatively new material in joint arthroplasty; there are no long-term reports, and only few mid-term results. Using radiostereometric analysis (RSA), we primarily determined whether vitamin E-infused highly cross-linked polyethylene (HXLPE/VitE) acetabular cups show less wear than ultra-high molecular weight polyethylene (UHMWPE) acetabular cups at 5 years after total hip arthroplasty (THA). We also assessed whether wear rates correlate with increasing cup inclination angles or cup sizes.Patients and methods - This is a 5-year follow-up of our previously reported randomized controlled trial of 62 patients with 3 years' follow-up, who received THA with either an HXLPE/VitE or a UHMWPE acetabular cup. At 5 years, 40 patients were analyzed (22 in the HXLPE/VitE and 18 in the UHMWPE group).Results - HXLPE/VitE cups continued to show less cumulative femoral head penetration than UHMWPE cups (HXLPE/VitE: 0.24 mm, UHMWPE: 0.45 mm; p < 0.001). Distribution of wear was also more even with HXLPE/VitE cups than with UHMWPE cups (p = 0.002). Moreover, the difference in PE wear between 1 and 5 years in both groups showed no statistically significant correlation with increasing cup inclination angles or cup sizes. Finally, no osteolysis and implant loosening occurred, and no revision surgeries were required.Interpretation - Wear rates continue to be lower in HXLPE/VitE cups than in UHMWPE cups at 5 years of follow-up without correlation with increasing cup inclination angles or cup sizes. Finally, HXLPE/VitE cups may have the potential to prevent osteolysis and implant loosening.

Indexed as

Arthroplasty, Replacement, HipHip ProsthesisPolyethyleneProsthesis DesignProsthesis FailureAgedFemaleHumansMaleMiddle AgedPolyethylenesRadiostereometric AnalysisVitamin EPolyethylenePolyethylenesultra-high molecular weight polyethyleneVitamin E

Identifiers

PMID33263447
PMCPMC8158183
OpenAlexW3106796427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.